Health TidingsCHMP Endorses Novo Nordisk’s Single-Dose Wegovy 7.2 mg Pen CHMP Endorses Novo Nordisk’s Single-Dose Wegovy 7.2 mg Pen Read Post »
New Drug ApprovalEC Grants EU‑Wide Approval for PYRUKYND in Thalassemia EC Grants EU‑Wide Approval for PYRUKYND in Thalassemia Read Post »
Clinical TrialsCHMP Backs AbbVie’s MAVIRET for Acute Hepatitis C in Adults and Children CHMP Backs AbbVie’s MAVIRET for Acute Hepatitis C in Adults and Children Read Post »
Clinical TrialsEli Lilly’s Foundayo Shows Up to 13% Weight Loss in Older Adults in ATTAI... Eli Lilly’s Foundayo Shows Up to 13% Weight Loss in Older Adults in ATTAI... Read Post »
New Drug ApprovalAstraZeneca and Daiichi Sankyo Secure FDA Approval for Datroway in Frontlin... AstraZeneca and Daiichi Sankyo Secure FDA Approval for Datroway in Frontlin... Read Post »
New Drug ApprovalGilead’s Hepcludex Becomes First FDA-Approved HDV Therapy Gilead’s Hepcludex Becomes First FDA-Approved HDV Therapy Read Post »
Health TidingsCHMP May 2026 Roundup: EU Backs New Treatments Across Oncology, Obesity, an... CHMP May 2026 Roundup: EU Backs New Treatments Across Oncology, Obesity, an... Read Post »
Health TidingsANKTIVA Plus BCG Shows Economic Edge in NMIBC CIS ANKTIVA Plus BCG Shows Economic Edge in NMIBC CIS Read Post »
Clinical TrialsInnovent’s IBI363 Demonstrates Durable Efficacy in NSCLC Innovent’s IBI363 Demonstrates Durable Efficacy in NSCLC Read Post »
Health TidingsRegeneron’s Otarmeni™ Accepted for EMA Review Under Accelerated Assessm... Regeneron’s Otarmeni™ Accepted for EMA Review Under Accelerated Assessm... Read Post »
Clinical TrialsBoehringer Ingelheim Unveils New Zongertinib and Obrixtamig Results Across ... Boehringer Ingelheim Unveils New Zongertinib and Obrixtamig Results Across ... Read Post »
New Drug ApprovalBayer Wins NMPA Approval for Kerendia in HFmrEF/HFpEF Bayer Wins NMPA Approval for Kerendia in HFmrEF/HFpEF Read Post »
New Drug ApprovalHERNEXEOS Secures China Approval for Untreated HER2-Mutant NSCLC HERNEXEOS Secures China Approval for Untreated HER2-Mutant NSCLC Read Post »
Health TidingsRegeneron Reports Strong Early Lynozyfic Data in AL Amyloidosis Regeneron Reports Strong Early Lynozyfic Data in AL Amyloidosis Read Post »
Health TidingsEMA Accepts TEV-‘749 Application for Adults With Schizophrenia EMA Accepts TEV-‘749 Application for Adults With Schizophrenia Read Post »
Clinical TrialsBiogen Ends BIIB122 Program, Denali Continues Trial in LRRK2 Carriers Biogen Ends BIIB122 Program, Denali Continues Trial in LRRK2 Carriers Read Post »
Clinical TrialsSobi’s Pozdeutinurad Delivers Positive Phase 3 Results in Gout Sobi’s Pozdeutinurad Delivers Positive Phase 3 Results in Gout Read Post »
Clinical TrialsBicycle Reports Positive Duravelo 2 Results for Zelenectide in mUC Bicycle Reports Positive Duravelo 2 Results for Zelenectide in mUC Read Post »
Clinical TrialsReCode’s Inhaled mRNA Therapy Shows First Clinical Activity in PCD ReCode’s Inhaled mRNA Therapy Shows First Clinical Activity in PCD Read Post »
Clinical TrialsLilly’s Retatrutide Achieves 30.3% Weight Loss in Phase 3 TRIUMPH-1 Trial Lilly’s Retatrutide Achieves 30.3% Weight Loss in Phase 3 TRIUMPH-1 Trial Read Post »
Mergers & AcquisitionsGilead Renews WHO Partnership to Fight Visceral Leishmaniasis Gilead Renews WHO Partnership to Fight Visceral Leishmaniasis Read Post »
Clinical TrialsInfex Advances RESP-X After Positive Bronchiectasis Phase IIa Results Infex Advances RESP-X After Positive Bronchiectasis Phase IIa Results Read Post »
Health Tidings Mergers & AcquisitionsJohnson & Johnson Builds AI-Powered Surgical Network in Abu Dhabi Johnson & Johnson Builds AI-Powered Surgical Network in Abu Dhabi Read Post »
Clinical TrialsBioMarin VOXZOGO Improves Growth and Reach in Children BioMarin VOXZOGO Improves Growth and Reach in Children Read Post »
Health TidingsFDA Grants Priority Review to Bayer’s Kerendia for T1D-Associated CKD FDA Grants Priority Review to Bayer’s Kerendia for T1D-Associated CKD Read Post »
Clinical TrialsPalvella Strengthens QTORIN’s FDA Path With New SELVA and TOIVA Data Palvella Strengthens QTORIN’s FDA Path With New SELVA and TOIVA Data Read Post »
Health Tidings Mergers & AcquisitionsBMS Integrates Claude AI into Research, Clinical Development, and Manufactu... BMS Integrates Claude AI into Research, Clinical Development, and Manufactu... Read Post »
Clinical TrialsSavara Reports New Phase 3 Biomarker Data Supporting Molgramostim in aPAP Savara Reports New Phase 3 Biomarker Data Supporting Molgramostim in aPAP Read Post »
Clinical TrialsRelay’s Zovegalisib Shows Rapid Lesion Reduction in Rare Vascular Disorde... Relay’s Zovegalisib Shows Rapid Lesion Reduction in Rare Vascular Disorde... Read Post »
Mergers & AcquisitionsIncyte Expands Molecular AI Collaboration With Genesis Therapeutics Incyte Expands Molecular AI Collaboration With Genesis Therapeutics Read Post »
Health TidingsFDA Backs Cullinan Therapeutics’ CLN-049 With Orphan Drug Status in AML FDA Backs Cullinan Therapeutics’ CLN-049 With Orphan Drug Status in AML Read Post »
Clinical TrialsRemepy Advanced Hybridopa After Positive Parkinson’s Trial Results Remepy Advanced Hybridopa After Positive Parkinson’s Trial Results Read Post »
Health TidingsPfizer’s 25vPnC Shows Improved Serotype 3 Protection in Infant Phase 2 St... Pfizer’s 25vPnC Shows Improved Serotype 3 Protection in Infant Phase 2 St... Read Post »
Clinical TrialsShionogi Advances Tapinarof With Positive Infant Atopic Dermatitis Data Shionogi Advances Tapinarof With Positive Infant Atopic Dermatitis Data Read Post »
Health TidingsImmunityBio’s ANKTIVA sBLA for Papillary NMIBC Accepted by FDA ImmunityBio’s ANKTIVA sBLA for Papillary NMIBC Accepted by FDA Read Post »
Clinical TrialsIpsen’s Dysport Holds Its Ground Against Botox in Head-to-Head Study Ipsen’s Dysport Holds Its Ground Against Botox in Head-to-Head Study Read Post »
Health TidingsNovo Nordisk Highlights New Semaglutide Data in MASH Ahead of EASL 2026 Novo Nordisk Highlights New Semaglutide Data in MASH Ahead of EASL 2026 Read Post »
GenericsSamsung Bioepis Launches Ustekinumab Biosimilar in Japan With NIPRO Samsung Bioepis Launches Ustekinumab Biosimilar in Japan With NIPRO Read Post »
Clinical TrialsANKTIVA Plus BCG Outperforms Approved NMIBC Therapies in AUA 2026 Analyses ANKTIVA Plus BCG Outperforms Approved NMIBC Therapies in AUA 2026 Analyses Read Post »
Clinical TrialsInnovent’s Dual-Target Antibody IBI3002 Shows Promise in Asthma Innovent’s Dual-Target Antibody IBI3002 Shows Promise in Asthma Read Post »
Health TidingsBayer Files Asundexian in U.S. and Japan After Positive Phase III Stroke Da... Bayer Files Asundexian in U.S. and Japan After Positive Phase III Stroke Da... Read Post »
Mergers & AcquisitionsHansa Licenses IDEFIRIX Rights to SERB in €115 Million Deal Hansa Licenses IDEFIRIX Rights to SERB in €115 Million Deal Read Post »
Clinical TrialsUCB Pushes BIMZELX Ahead of SKYRIZI in Psoriatic Arthritis Showdown UCB Pushes BIMZELX Ahead of SKYRIZI in Psoriatic Arthritis Showdown Read Post »
Mergers & AcquisitionsIncyte Collaborates With Edison Scientific on AI-Driven Drug Discovery Incyte Collaborates With Edison Scientific on AI-Driven Drug Discovery Read Post »
Health TidingsLantern Advances LP-300 Program After FDA Backs HARMONIC Trial Amendments Lantern Advances LP-300 Program After FDA Backs HARMONIC Trial Amendments Read Post »
Clinical TrialsWave Expands Evidence for WVE-006 in Lung and Liver Manifestations of AATD Wave Expands Evidence for WVE-006 in Lung and Liver Manifestations of AATD Read Post »
Health TidingsTakeda Faces $885 Million Jury Verdict in AMITIZA Antitrust Case Takeda Faces $885 Million Jury Verdict in AMITIZA Antitrust Case Read Post »
Clinical TrialsAlterity Pushes ATH434 Toward Phase 3 With New MSA Disease-Modifying Signal... Alterity Pushes ATH434 Toward Phase 3 With New MSA Disease-Modifying Signal... Read Post »
Clinical TrialsBioMarin Sees Biomarker Win Fade Against Clinical Reality in ENERGY 3 Trial BioMarin Sees Biomarker Win Fade Against Clinical Reality in ENERGY 3 Trial Read Post »
Clinical TrialsSanofi Reports Positive Phase 2 Results for Efdoralprin Alfa in AATD Sanofi Reports Positive Phase 2 Results for Efdoralprin Alfa in AATD Read Post »
